Harvard big-shots Kevin Eggan and Clifford Woolf launch ALS startup with exclusive Q-State tech

A group of well-known Harvard professors has launched a new ALS spinout to take on research Big Pharma wasn’t tackling fast enough. The new company, called QurAlis (pronounced “cure-al-is”), was founded by a couple of stem cell pioneers at Harvard: Kevin Eggan (the guy who developed the first ALS patient-derived stem cell models) and Clifford … Continue reading Harvard big-shots Kevin Eggan and Clifford Woolf launch ALS startup with exclusive Q-State tech